Guess which ASX medical share has exploded 275% in a month?

It's been a brilliant month for this medical technology company.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The 4DMedical share price has more than tripled in a month 
  • The company has developed patented XV technology for detecting ventilation in the lungs 
  • 4DMedical is meeting with US congressmen in a bid to leverage its product in the US market

The S&P/ASX 200 Health Care Index (ASX: XHJ) has climbed 3% in the last month, but this ASX medical share has soared far higher.

The 4DMedical Ltd (ASX: 4DX) share price has rocketed 278% since market close on 3 April from 30 cents to $1.14.

So why has this ASX medical share had such a stellar run lately?

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.

Image source: Getty Images

What's happening?

4DMedical shares have been lifting amid a raft of positive announcements from the company.

In early April, 4DMedical advised it had signed its "first US hospital Software as a Service (SaaS) contract".

Under a five-year contract with the University of Miami, 4DMedical will provide XV technology to enable the processing of patient data. XV technology enables physicians to detect the level of airflow in the lungs. 

4DMedical described the deal as a "significant milestone" for the company's commercialisation strategy in the US.

Then on 13 April, 4DMedical provided further details on this sales contract. Under its terms, a minimum of $1 million to $1.5 million in fees is guaranteed to be paid to the company over a five-year term.

Meanwhile, on 26 April, 4DMedical updated the market with a quarterly report. Receipts from customers grew 67% to $1.2 million in the third quarter. The company reported a cash balance at 31 March of $36.8 million.

The company advised it is continuing to meet with US congress members on Capitol Hill to outline the company's XV Technology and its potential to deliver on PACT Act healthcare for veterans. The former US Secretary for Veterans Affairs, Dr David Shulkin, has recently joined 4DMedical in an advisory role.

Finally, on 1 May, 4DMedical advised it had conducted its first commercial scanning within Veterans Health Administration. This took place at the Harry S. Truman Memorial Veterans Hospital.

Commenting on the news, 4DMedical CEO and founder Andreas Fouras said:

A vision to enable better care for Veterans is core to 4DMedical's mission and culture. I am delighted to share the success of the first commercial scan at Harry S. Truman Memorial Veterans Hospital, completed by our team working alongside VA [Veterans Affairs] medical professionals.

Share price snapshot

The 4DMedical share price has soared 68% in the last year and 170% in the year to date.

This ASX medical share has a market capitalisation of about $334.7 million based on the latest share price.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman leans forward with her hand behind her ear, as if trying to hear information.
Healthcare Shares

Why everyone selling Cochlear shares right now could regret it in 3 years

Cochlear shares are down 65%. Here's why investors selling up right now could look back and wish they'd done the…

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Healthcare Shares

Here's what brokers tip for CSL shares over the next 12 months

The beaten-down biotech company's shares are still falling.

Read more »

three excited doctors with hands in the air
Healthcare Shares

Pro Medicus announces $16m US contract renewal

Pro Medicus secures a major US contract renewal, strengthening its US footprint and underlining continued client retention.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

How much higher could Pro Medicus shares go? 2 brokers weigh in

New contract wins and a positive take on AI are tailwinds for this company.

Read more »

A bored man sits at his desk, flat after seeing the latest news on the share market.
Healthcare Shares

Why did CSL shares crash 22% in May?

Things went from bad to worse for this fallen giant last month.

Read more »

A man stands in front of a chart with an arrow going down and slaps his forehead in frustration.
Healthcare Shares

Why is this ASX share crashing 97% today?

It isn't often that a share falls by this amount in a single session.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

3 ASX 200 healthcare shares to buy while they're on sale

The ASX 200 Health Care Index is the worst-performing sector for 2026 so far.

Read more »

Doctor checking patient's spine x-ray image.
Healthcare Shares

Why AI is making Pro Medicus shares a once-in-a-generation buy

Pro Medicus shares are down on AI fears. Here's why AI is actually making the company a once-in-a-generation buy opportunity.

Read more »